OXYPHENBUTAZONE HYDRATE (CAS 7081-38-1) — formula C19H20N2O3, molecular weight 324.4; category organic chemicals.
| CAS Number | 7081-38-1 |
|---|---|
| Molecular Formula | C19H20N2O3 |
| Molecular Weight | 324.4 |
| Melting Point | 96 |
| LogP | 2.72 |
| Applications | Uses: MEDICATION, MEDICATION (VET), Use Classification: Pharmaceuticals, Methods of Manufacturing: HAFLIGER, US PATENT 2, 745, 783 (1956 TO GEIGY): PFISTER, HAFLIGER, HELV CHIM ACTA 40, 395 (1957)., Formulations, Preparations: OXYPHENBUTAZONE, NF (TANDEARIL), IS MARKETED IN 100-MG TABLETS., General Manufacturing Information: OXYPHENBUTAZONE IS HYDROXY ANALOG OF PHENYLBUTAZONE & ONE OF MAJOR ACTIVE METABOLITES OF PARENT DRUG. ... OXYPHENBUTAZONE HAS SAME SPECTRUM OF ACTIVITY, THERAPEUTIC USES, INTERACTIONS, & TOXICITY AS PARENT COMPD, & IT SHARES SAME INDICATIONS, DANGERS, & CONTRAINDICATIONS FOR CLINICAL USE. |
| Category | Organic Chemicals |
Documented applications: Uses: MEDICATION, MEDICATION (VET), Use Classification: Pharmaceuticals, Methods of Manufacturing: HAFLIGER, US PATENT 2, 745, 783 (1956 TO GEIGY): PFISTER, HAFLIGER, HELV CHIM ACTA 40, 395 (1957)., Formulations, Preparations: OXYPHENBUTAZONE, NF (TANDEARIL), IS MARKETED IN 100-MG TABLETS., General Manufacturing Information: OXYPHENBUTAZONE IS HYDROXY ANALOG OF PHENYLBUTAZONE & ONE OF MAJOR ACTIVE METABOLITES OF PARENT DRUG. ... OXYPHENBUTAZONE HAS SAME SPECTRUM OF ACTIVITY, THERAPEUTIC USES, INTERACTIONS, & TOXICITY AS PARENT COMPD, & IT SHARES SAME INDICATIONS, DANGERS, & CONTRAINDICATIONS FOR CLINICAL USE..
OXYPHENBUTAZONE HYDRATE is a carbon-based organic compound with CAS registry number 7081-38-1 and molecular formula C19H20N2O3 (molecular weight 324.4), belonging to the organic chemicals segment of chemical raw materials.
CAS number: 7081-38-1
Its molecular formula C19H20N2O3 comprises 19 C, 20 H, 2 N, 3 O atoms.
Also known as: OXYPHENBUTAZONE HYDRATE · 化合物 Oxyphenbutazone monohydrate
Category: organic chemicals
The CAS registry number of OXYPHENBUTAZONE HYDRATE is 7081-38-1.
Molecular formula C19H20N2O3, molecular weight 324.4.
It is also registered under: OXYPHENBUTAZONE HYDRATE, 化合物 Oxyphenbutazone monohydrate.
Recorded applications: Uses: MEDICATION, MEDICATION (VET), Use Classification: Pharmaceuticals, Methods of Manufacturing: HAFLIGER, US PATENT 2, 745, 783 (1956 TO GEIGY): PFISTER, HAFLIGER, HELV CHIM ACTA 40, 395 (1957)., Formulations, Preparations: OXYPHENBUTAZONE, NF (TANDEARIL), IS MARKETED IN 100-MG TABLETS., General Manufacturing Information: OXYPHENBUTAZONE IS HYDROXY ANALOG OF PHENYLBUTAZONE & ONE OF MAJOR ACTIVE METABOLITES OF PARENT DRUG. ... OXYPHENBUTAZONE HAS SAME SPECTRUM OF ACTIVITY, THERAPEUTIC USES, INTERACTIONS, & TOXICITY AS PARENT COMPD, & IT SHARES SAME INDICATIONS, DANGERS, & CONTRAINDICATIONS FOR CLINICAL USE..
Category: Organic Chemicals.
Independent reference data for OXYPHENBUTAZONE HYDRATE (CAS 7081-38-1), compiled from public chemistry databases.
| CAS 号 | 7081-38-1 |
|---|---|
| PubChem CID | 4641 |
| 分子式 | C19H20N2O3 |
| IUPAC 名称 | 4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione |
| UNII（FDA） | A7D84513GV |
| Molecular Weight | 324.4 |
|---|---|
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 5 |
| Exact Mass | 324.14739250 |
| Monoisotopic Mass | 324.14739250 |
| Topological Polar Surface Area | 60.9 |
| Heavy Atom Count | 24 |
| Melting Point | 96 |
|---|---|
| Solubility | 60 |
| LogP | 2.72 |
| LogP | 3.04 |
| Collision Cross Section | 179.21 Ų [M+H]+ |
| Collision Cross Section | 184.74 Ų [M-H]- |
oxyphenbutazone; 129-20-4; Oxyphenylbutazone; Tandearil; Flogitolo; Flogoril; Frabel; Oxalid; Neo-Farmadol; Crovaril; Oxazolidin; Visubutina; Oxifenylbutazon; Oxiphenbutazone; Butapirone; Californit
| 已通报的危害声明 | H302 (100%), H400 (100%) |
|---|
化合物 Oxyphenbutazone monohydrate · CAS 7081-38-1 · C19H20N2O3. UNII A7D84513GV. Melting Point: 96; Solubility: 60; LogP: 2.72.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.